Ind-Swift Laboratories Limited accepted the resignation of Mr. Prabhat Khurana as Independent Director, effective from the close of business hours on June 22, 2026. The resignation was submitted via email on June 22, 2026, citing personal and professional commitments as the reason for his departure. The Board of Directors recorded its appreciation for the guidance provided by Mr. Khurana during his association with the company.

Resignation Details

Mr. Prabhat Khurana resigned from his position as Independent Director, including his membership on all Board Committees. He confirmed that there are no material reasons for his resignation other than those stated in his letter. The intimation was made to the stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Disclosures and Regulatory Compliance

The company disclosed that Mr. Khurana does not hold directorships in any other listed entities. The resignation letter and detailed reasons were provided as annexures to the regulatory filing. The company confirmed that all necessary statutory and regulatory formalities would be completed regarding the change.

Ind-Swift Laboratories Ltd has amended its internal code governing fair disclosure and insider trading to align with regulatory requirements. The Board of Directors approved the amendment to the ‘Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and Immediate Relatives of Designated Persons, and Legitimate Purpose Policy’ via a circular resolution passed on June 22, 2026.

The revised code is enacted pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. It establishes internal procedures for the preservation of Unpublished Price Sensitive Information (UPSI) and regulates trading by designated persons, including promoters, directors, and functional employees. The policy mandates pre-clearance for trades, defines trading windows, and sets forth disclosure requirements for transactions exceeding ₹1,000,000 in a quarter.

Key Provisions of the Amended Code

The updated framework designates the Company Secretary or a financially literate senior officer as the Compliance Officer, responsible for monitoring adherence to the rules and implementing the code under the Board's supervision. It defines UPSI as information not generally available that could materially affect securities prices, covering financial results, dividends, capital structure changes, and key management personnel changes.

Trading Restrictions and Disclosures

Designated persons and insiders are prohibited from trading while in possession of UPSI. The code specifies that the trading window shall be closed during critical periods such as financial result declarations and dividend announcements. It also mandates that designated persons execute trades within seven trading days of receiving pre-clearance and report details to the Compliance Officer within two trading days of execution.

The company has ensured that the amended code is hosted on its website and has intimated the stock exchanges regarding the approval. The changes reinforce the company's commitment to preventing insider trading and ensuring uniform dissemination of price-sensitive information.